Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBluefield Solar Regulatory News (BSIF)

Share Price Information for Bluefield Solar (BSIF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 106.40
Bid: 106.40
Ask: 106.80
Change: -0.20 (-0.19%)
Spread: 0.40 (0.376%)
Open: 106.80
High: 106.80
Low: 106.40
Prev. Close: 106.60
BSIF Live PriceLast checked at -
Bluefield Solar Income Fund is an Investment Trust

To provide Shareholders with an attractive return, principally in the form of quarterly income distributions by being invested primarily in solar energy assets located in the UK.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Interim Dividend

26 Jan 2024 07:00

RNS Number : 9798A
Bluefield Solar Income Fund Limited
26 January 2024
 

26 January 2024

 

Bluefield Solar Income Fund Limited

('Bluefield Solar' or the 'Company')

 

First Interim Dividend Announcement

 

Bluefield Solar (LON: BSIF), the London listed UK income fund focused primarily on acquiring and managing solar energy assets, is pleased to announce the Company's first interim dividend for the financial year ending 30 June 2024 (the 'First Interim Dividend').

The First Interim Dividend of 2.20 pence per Ordinary Share (January 2023: 2.10 pence per Ordinary Share) will be payable to Shareholders on the register as at 9 February 2024, with an associated ex-dividend date of 8 February 2024 and a payment date on or around 9 March 2024.

The Board is pleased to reaffirm its guidance of a full year dividend of not less than 8.80 pence per Ordinary Share for the financial year ending 30 June 2024 (2023: 8.60 pence). This is expected to be covered by earnings and to be post debt amortisation.

 

- Ends -

 

 

For further information:

 

Bluefield Partners LLP (Company Investment Adviser) James Armstrong / Neil Wood / Giovanni Terranova

 

 

 

Tel: +44 (0) 20 7078 0020 www.bluefieldllp.com

 

Deutsche Numis (Company Broker) Tod Davis / David Benda / Matt Goss

 

 

Tel: +44 (0) 20 7260 1000 www.dbnumis.com

 

Ocorian(Company Secretary & Administrator) Chezi Hanford

 

 

Tel: +44 (0) 1481 742 742 www.ocorian.com

 

Media enquiries:Buchanan (PR Adviser) Henry Harrison-Topham / Henry Wilson

 

Tel: +44 (0) 20 7466 5000 www.buchanan.uk.com BSIF@buchanan.uk.com

About Bluefield Solar

 

Bluefield Solar is a London listed income fund focused primarily on acquiring and managing solar energy assets. Not less than 75% of the Company's gross assets will be invested into UK solar assets. The Company can also invest up to 25% of its gross assets into other technologies, such as wind and storage. Bluefield Solar owns and operates a UK portfolio of 834MW, comprising 776MW of solar and 58MW of onshore wind.

 

Further information can be viewed at www.bluefieldsif.com

 

 

 

About Bluefield Partners

 

Bluefield Partners LLP was established in 2009 and is an investment adviser to companies and funds investing in renewable energy infrastructure. It has a proven record in the selection, acquisition and supervision of large-scale energy assets in the UK and Europe. The team has been involved in over £6.5 billion renewable funds and/or transactions in both the UK and Europe, including over £1 billion in the UK since December 2011.

 

Bluefield Partners LLP has led the acquisitions of, and currently advises on, over 100 UK based solar PV assets that are agriculturally, commercially or industrially situated. Based in its London office, it is supported by a dedicated and experienced team of investment, legal and portfolio executives.  Bluefield Partners LLP was appointed Investment Adviser to Bluefield Solar in June 2013.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVSEUFAIELSEIF
Date   Source Headline
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20243:02 pmRNSDirector/PDMR Shareholding
28th Feb 20243:07 pmRNSDirector/PDMR Shareholding
28th Feb 20247:00 amRNSInterim Results to 31 December 2023
15th Feb 20247:00 amRNSNAV Update and £20m Share Buyback Programme
26th Jan 20247:00 amRNSFirst Interim Dividend
25th Jan 20247:00 amRNSCompletion of Phase One of Strategic Partnership
23rd Jan 20244:39 pmRNSDirector/PDMR Shareholding
19th Jan 20247:00 amRNSNotice of Interim Results
22nd Dec 20237:00 amRNSStrategic Partnership with GLIL Infrastructure
1st Dec 20237:00 amRNSChange to Director Roles and Responsibilities
28th Nov 20233:55 pmRNSResult of AGM
27th Nov 20238:00 amRNSHolding(s) in Company
20th Nov 20237:01 amRNSChange to Director Roles and Responsibilities
20th Nov 20237:00 amRNSDirector Appointment
16th Nov 20235:59 pmRNSCorrection - Unaudited NAV as at 30 September 2023
16th Nov 20237:00 amRNSUnaudited NAV as at 30 September 2023
27th Oct 20237:00 amRNSNotice of AGM
23rd Oct 20239:47 amRNSHolding(s) in Company
5th Oct 20237:00 amRNSAnalyst and Investor Site Visit
4th Oct 20234:31 pmRNSUpdate from QuotedData
2nd Oct 20234:47 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSDirector Retirement and New Audit Chair
28th Sep 20237:01 amRNSFourth Interim Dividend
28th Sep 20237:00 amRNSAnnual Report for the Year Ended 30 June 2023
13th Sep 20232:40 pmRNSHolding(s) in Company
5th Sep 20233:27 pmRNSHolding(s) in Company
24th Aug 202312:47 pmRNSDirector/PDMR Shareholding
23rd Aug 20235:03 pmRNSDirector/PDMR Shareholding
18th Aug 202312:10 pmRNSDirector/PDMR Shareholding
18th Aug 202312:08 pmRNSDirector/PDMR Shareholding
17th Aug 20233:58 pmRNSDirector/PDMR Shareholding
17th Aug 20237:00 amRNSUnaudited Net Asset Value as of 30 June 2023
7th Aug 202312:12 pmRNSThird Interim Dividend Announcement - Replacement
7th Aug 20237:00 amRNSThird Interim Dividend Announcement
22nd Jun 20237:00 amRNSRCF Increase and Extension
7th Jun 20237:00 amRNSConclusion of Audit Tender Process
18th May 20235:21 pmRNSChange to Director Roles and Responsibilities
11th May 20237:00 amRNSUnaudited NAV 31 Mar 2023 and 2nd Interim Dividend
2nd May 20237:00 amRNSRe-Financing, Increase & Extension of NatWest Loan
17th Mar 20239:44 amRNSDirector Declaration
8th Mar 20237:00 amRNSChange of Registrar
28th Feb 20237:00 amRNSInterim Results to 31 December 2022
22nd Feb 20233:28 pmRNSDirector Retirement
6th Feb 20237:00 amRNSNotice of Interim Results
23rd Jan 20237:00 amRNSFirst Interim Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.